Holen Sie sich die Stockscreener-App
436.95
1.62%
-7.20
Schlusskurs vom Vortag:
$444.15
Offen:
$444.48
24-Stunden-Volumen:
902.30K
Relative Volume:
0.92
Marktkapitalisierung:
$42.93B
Einnahmen:
$3.77B
Nettoeinkommen (Verlust:
$449.25M
KGV:
55.62
EPS:
7.8556
Netto-Cashflow:
$240.68M
1W Leistung:
+0.73%
1M Leistung:
+4.37%
6M Leistung:
+36.96%
1J Leistung:
+30.48%
1-Tages-Spanne:
$431.99
$448.39
1-Wochen-Bereich:
$422.82
$449.12
52-Wochen-Spanne:
$282.77
$454.54
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, NTRA, A, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
436.95 | 42.93B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-09 | Fortgesetzt | UBS | Buy |
| 2026-08-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-08-05 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-07-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-06-26 | Fortgesetzt | Bernstein | Outperform |
| 2026-06-11 | Eingeleitet | Piper Sandler | Neutral |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Outperform |
| 2026-04-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-10 | Fortgesetzt | Citigroup | Buy |
| 2026-02-10 | Fortgesetzt | Evercore ISI | In-line |
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Should You Invest in the First Trust Water ETF (FIW)? - Zacks Investment Research
Waters Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Waters Corp Price Target Raised to $500.00/Share From $460.00 by Barclays - Moomoo
Waters Corporation (WAT) Stock Forecasts - Yahoo Finance
Fidelity Advisor Health Care Fund's Waters Corp(WAT) Holding History - GuruFocus
Waters Corporation stock hits all-time high at 449.0 USD - Investing.com
CellCarta, Waters Corporation collaborate on companion diagnostics - Yahoo Finance
Waters Corp (WAT) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 94/100 - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp stock after-hours at EUR 387.60: plus 2.57 percent - AD HOC NEWS
Should You Invest in the Invesco Water Resources ETF (PHO)? - Zacks Investment Research
Instead of cash director fees, Heather Knight receives 57.41 stock units at Waters (WAT). - Stock Titan
Stock replaces cash for director fees at Waters (WAT); Wei Jiang receives 57.41 units. - Stock Titan
Waters Corp (WAT) Shares Fall 3.1% -- What GF Score of 94 Tells Investors - GuruFocus
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corp Is Maintained at Buy by Guggenheim - Moomoo
An earnings call is set for Nov. 3; Waters' replay stays available until at least Dec. 1. - Stock Titan
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call - Yahoo Finance
Waters Corporation (WAT) Stock Forecasts - Yahoo Finance
If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today - Benzinga
Waters Corp (WAT): GF Score of 94 Signals Strong Outperformance Potential - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push - Yahoo! Finance Canada
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push - Yahoo Finance
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum - Yahoo Finance
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corporation stock hits all-time high at 433.09 USD - Investing.com
Waters Corp stock rises 0.4 percent ahead of the open - ad-hoc-news.de
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance UK
Robust Results Lifted Waters (WAT) - Yahoo Finance
Waters Corp at JPMorgan U.S. All Stars Conference Transcript - GuruFocus
Waters Corp stock gains 3.35 percent as revenue recovery matters - AD HOC NEWS
Waters Corp stock heads into the open after a 1.9 percent drop - AD HOC NEWS
Waters Corp stock gains attention after new Outperform rating and USD 435 target - AD HOC NEWS
Waters Corp stock heads into the open after a 1.9 percent drop - AD HOC NEWS
Waters Stock Price Forecast. Should You Buy WAT? - StockInvest.us
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry - Yahoo Finance
How Is Waters Corporation's Stock Performance Compared to Other Health Care Stocks? - Barchart.com
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp (WAT): GF Score of 94 Signals Strong Outperformance Potential - GuruFocus
Waters Corporation stock hits 52-week high at 427.1 USD - Investing.com
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp stock gains after UBS upgrade and conference news - ad-hoc-news.de
Waters Corp CEO Udit Batra to speak at J.P. Mor... - Pluang
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference - Yahoo Finance
Waters Corp stock heads into the open after a 0.6% dip - ad-hoc-news.de
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Waters Corp-Aktie (WAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KUEBLER CHRISTOPHER A | Director |
Aug 06 '26 |
Sale |
397.94 |
3,626 |
1,442,930 |
17,808 |
| KUEBLER CHRISTOPHER A | Director |
Aug 06 '26 |
Proposed Sale |
397.94 |
3,626 |
1,442,930 |
0 |
| Jiang Wei | Director |
Mar 16 '26 |
Buy |
289.46 |
500 |
144,730 |
3,441 |
| FEARON RICHARD H | Director |
Mar 06 '26 |
Buy |
306.34 |
1,000 |
306,340 |
3,302 |
| KUEBLER CHRISTOPHER A | Director |
Nov 05 '25 |
Option Exercise |
130.35 |
3,761 |
490,246 |
18,796 |
1.53%
2.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):